Gems u-turn on Dr Bvuma's cancer treatment drug payout
Dr Sipho Bvuma's fight to get the Government Employees Medical Scheme (Gems) to pay for his cancer treatment has ended in victory after the company buckled under pressure and agreed to cover his medical bills.
This comes after Gems has refused to pay for Dr Bvuma's expensive brain cancer treatment, which he believed would prolong his life and move him into remission. stage.
Speaking on the Xolani Gwala Show, Dr Stan Moloabi - Gems COO said it has a responsibility as the medical scheme towards all the Gems members.
The decision not to fund Dr Bvuma's medication was taken for review to the oncology panel, he adds. On the advice they gave, they then instituted an urgent ex gratia process - which is the only process that allows the scheme to fund outside the rules.
We have always been sensitive to the matter that our member Dr Sipho Bvuma is faced with a very serious life-threatening matter. We have considered all the options we had, and they had to be reviewed by a panel of experts, and in this instance, they advised that we fund Dr Bvuma's medical bills.Dr Stan Moloabi - GEMS COO
The company had previously argued in court papers that paying for the treatment which could cost R583,000 would not be viable in Bvuma's case, as the drug in question, Keytruda, is not registered in SA to treat his condition, and in addition, there was no scientific evidence that it can save his life.
Click below to listen to the full interview: